iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionRobertson Stephens Wealth Management, LLC
Latest Disclosed Ownership12,001 shares
Latest Disclosed Value $ 2,026,432
Robertson Stephens Wealth Management, LLC reports 5.88% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 28, 2026 - Robertson Stephens Wealth Management, LLC filed a 13F-HR form disclosing ownership of 12,001 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $2,026,432 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 11,334 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 5.88% during the quarter. The current value of the position is $1,572,731 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 12,001 667 5.88 2,026 5.96 0.0568
2026-02-02 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,334 8,891 363.94 1,913 443.18 0.0499
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,443 -1 -0.04 353 13.92 0.0107
2025-07-24 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,444 -28 -1.13 309 -2.22 0.0098
2025-04-17 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,472 -256 -9.38 316 -12.22 0.0109
2025-01-27 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,728 -60 -2.15 361 -11.33 0.0128
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,788 510 22.39 406 30.13 0.0147
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,278 620 37.39 313 37.44 0.0157
2024-05-15 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,658 156 10.39 227 11.82 0.0121
2024-02-06 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,502 1,502 204 0.0124
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -1,869 -100.00 0 -100.00
2023-08-11 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,869 0 0.00 237 -1.66 0.0168
2023-05-11 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,869 1 0.05 241 -1.63 0.0186
2023-02-14 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,868 -47 -2.45 245 9.38 0.0239
2022-11-14 2022-09-30 13F iShares Nasdaq Bio ETF ISHARES BIOTECH 464287556 1,915 47 2.52 224 2.28 0.0234
2022-08-12 2022-06-30 13F iShares Nasdaq Bio ETF ISHARES BIOTECH 464287556 1,868 0 0.00 219 -9.88 0.0207
2022-05-16 2022-03-31 13F iShares Nasdaq Bio ETF ISHARES BIOTECH 464287556 1,868 0 0.00 243 -14.74 0.0204
2022-02-14 2021-12-31 13F iShares Nasdaq Bio ETF ISHARES BIOTECH 464287556 1,868 50 2.75 285 -3.06 0.0240
2021-11-10 2021-09-30 13F iShares Nasdaq Bio ETF ISHARES BIOTECH 464287556 1,818 0 0.00 294 -1.01 0.0332
2021-08-17 2021-06-30 13F iShares Nasdaq Bio ETF ISHARES BIOTECH 464287556 1,818 -501 -21.60 297 -14.90 0.0357
2021-05-07 2021-03-31 13F iShares Nasdaq Bio ETF NASDAQ BIOTECH 464287556 2,319 161 7.46 349 7.06 0.0558
2021-02-10 2020-12-31 13F iShares Nasdaq Bio ETF NASDAQ BIOTECH 464287556 2,158 0 0.00 326 11.64 0.0681
2020-11-10 2020-09-30 13F iShares Nasdaq Bio ETF NASDAQ BIOTECH 464287556 2,158 2,158 292 0.0717
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.